Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.60
+0.26500.58%
Volume:2.26M
Turnover:103.75M
Market Cap:201.67B
PE:11.39
High:46.16
Open:45.82
Low:45.52
Close:45.33
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:1.23
T/O Rate:0.07%
Dividend:1.72
Dividend Rate:3.78%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.19
PE(LYR):12.59

Loading ...

Market Chatter: Novo Nordisk's Wegovy Approved for Fatty Liver Disease Treatment by India's Drug Regulator

MT Newswires Live
·
Jul 17

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 2.11%

TIPRANKS
·
Jul 17

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires Live
·
Jul 16

United Laboratories Unit Receives $13.5 Million Milestone Payment From Novo Nordisk

MT Newswires Live
·
Jul 16

United Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT251

TIPRANKS
·
Jul 16

Moderately bullish activity in Novo Nordisk with shares up 2.46%

TIPRANKS
·
Jul 16

Sector Update: Healthcare

MT Newswires Live
·
Jul 16

Novo Nordisk Expands Cardiometabolic Reach With New Heart Failure–Obesity Trial

TIPRANKS
·
Jul 16

Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 16

Novo Nordisk announces European Commission approval of Wegovy pill

TIPRANKS
·
Jul 16

European Equities Traded in the US as American Depositary Receipts Advance Wednesday

MT Newswires Live
·
Jul 15

Novo Nordisk Rises as Oral Wegovy Captures 89% of US Oral Weight-Loss Prescriptions vs Eli Lilly

Market Focus
·
Jul 15

This Wall Street 'theme-o-meter' Has a Clear Message: the Artificial-intelligence Bull Market is Back

Dow Jones
·
Jul 15

Novo Nordisk Takes Early Lead in Oral Weight-Loss Drug Market, Eli Lilly Aims to Catch Up

Deep News
·
Jul 15

In the Weight-loss Wars, Novo's Obesity Pill is Pulling Way Ahead of Lilly's

Dow Jones
·
Jul 15

Novo Nordisk’s New Diabetes Bet: What the UBT251 Trial Could Mean for NVO Investors

TIPRANKS
·
Jul 15

Novo Nordisk Ramps Up Share Buybacks Under DKK 15 Billion Programme

TIPRANKS
·
Jul 14

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 14

Novo Nordisk announces new data from phase 3 FRONTIER4 study of denecimig

TIPRANKS
·
Jul 12

Novo Nordisk’s Hemophilia Drug Delivers Strong Results, but Analysts See 10% Downside for NVO Stock

TIPRANKS
·
Jul 12